Table 3.
Multiple regression analyses
Independent variables | HbA1c (R2 = 0.20) |
FPG (R2 = 0.15) |
2-h OGTT glucose (R2 = 0.22) |
SiOGTT (R2 = 0.86) |
||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
B | SE B | β | P | B | SE B | β | P | B | SE B | β | P | B | SE B | β | P | |
Constant | 11.29 | 1.04 | 5.8 × 10−22 | 14.06 | 1.66 | 1.3 × 10−15 | 37.02 | 4.20 | 1.1 × 10−16 | 0.08 | 0.007 | 2.4 × 10−24 | ||||
VO2max | −0.06 | 0.01 | −0.83 | 4.8 × 10−9 | −0.10 | 0.02 | −0.68 | 3.7 × 10−8 | −0.32 | 0.04 | −0.87 | 7.3 × 10−13 | 0.0005 | 0.00007 | 0.34 | 1.1 × 10−10 |
Age | −0.02 | 0.01 | −0.29 | 0.001 | −0.02 | 0.01 | −0.17 | 0.04 | −0.08 | 0.03 | −0.21 | 0.006 | 0.0002 | 0.00005 | 0.13 | 7.6 × 10−5 |
Sex | −0.30 | 0.21 | −0.16 | 0.15 | −1.03 | 0.32 | −0.32 | 0.002 | −2.84 | 0.82 | −0.34 | 0.0006 | 0.007 | 0.001 | 0.20 | 4.0 × 10−6 |
Weight | −0.03 | 0.01 | −0.43 | 0.006 | −0.04 | 0.01 | −0.41 | 0.003 | −0.12 | 0.03 | −0.48 | 0.0003 | 0.0001 | 0.00006 | 0.13 | 0.02 |
BMI | 0.04 | 0.03 | 0.25 | 0.14 | 0.09 | 0.04 | 0.30 | 0.05 | 0.18 | 0.11 | 0.23 | 0.10 | −0.003 | 0.0002 | −0.81 | 1.5 × 10−31 |
Fat % |
−0.02 |
0.01 |
−0.29 |
0.03 |
−0.04 |
0.02 |
−0.29 |
0.01 |
−0.10 |
0.04 |
−0.26 |
0.02 |
−0.0001 |
0.00007 |
−0.09 |
0.05 |
Early-phase GSISOGTT (R2 = 0.18) |
Late-phase GSISOGTT (R2 = 0.18) |
Early-phase DIOGTT (R2 = 0.33) |
Late-phase DIOGTT (R2 = 0.32) |
|||||||||||||
Independent variables |
B |
SE B |
β |
P |
B |
SE B |
β |
P |
B |
SE B |
β |
P |
B |
SE B |
β |
P |
Constant | 29,034 | 14,130 | 0.04 | 195,511 | 100,528 | 0.05 | 3,130 | 770 | 0.0001 | 18,623 | 5,346 | 0.0006 | ||||
VO2max | −6,057 | 2,278 | −0.32 | 0.008 | −31,946 | 16,306 | −0.24 | 0.03 | 16.8 | 8.0 | 0.22 | 0.04 | 96.7 | 55.5 | 0.23 | 0.04 |
Age | −240 | 126 | −0.16 | 0.06 | −1,339 | 899 | −0.13 | 0.14 | −1.1 | 5.2 | −0.02 | 0.84 | 33.6 | 36.3 | 0.08 | 0.36 |
Sex | 1,644 | 4,057 | 0.05 | 0.69 | −4,922 | 28,840 | −0.02 | 0.87 | 172 | 163 | 0.11 | 0.29 | 513 | 1133 | 0.05 | 0.65 |
Weight | 538 | 166 | 0.51 | 0.001 | 2,574 | 1178 | 0.35 | 0.03 | 17.3 | 6.4 | 0.38 | 0.007 | 83.4 | 44.4 | 0.26 | 0.06 |
BMI | −223 | 502 | −0.07 | 0.66 | −649 | 3,571 | −0.03 | 0.86 | −121 | 21 | −0.90 | 1.4 × 10−8 | −785 | 142 | −0.85 | 9.4 × 10−8 |
Fat % | −23 | 220 | −0.02 | 0.92 | 1,640 | 1,579 | 0.16 | 0.30 | 10.9 | 9.4 | 0.17 | 0.25 | 132 | 66 | 0.30 | 0.05 |
In a cohort representative of the whole glucose tolerance continuum, we determined the relative contributions of VO2max and other independent variables such as age, sex, body weight, BMI, and whole-body fat percentage to the variance of glycemic control (HbA1c, fasting glucose [FPG], 2-h OGTT glucose), SiOGTT, GSISOGTT, and DIOGTT using a forced-entry multiple regression method. Dependent variables are the actual values and not log transformed. The statistical significance of β values is indicated by the individual P values. B, the unstandardized β, which represents the change in the dependent variable resulting from 1 unit change in the independent variable; SE B, the SE of β; β, standardized β, which represents the change in the dependent variable resulting from 1 SD change in the independent variable.